The Weston Brain Institute (the “Institute”) supports research that accelerates the development of therapeutics for neurodegenerative diseases of aging. To help achieve this, the Institute addresses gaps and inefficiencies in the funding market by supporting high-risk, high-reward translational projects, while leveraging world-class business and scientific expertise in a fast and flexible granting process.
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs to manage these diseases will rise significantly within a generation.
Meeting this challenge requires pioneering approaches to accelerating treatments. The Canada: Rapid Response program was created to provide seed funding for novel, high-risk, high-reward, translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging.
PARKINSON'S & RELATED DISEASE Groups
- Parkinson’s disease
- Dementia with Lewy bodies
- Multiple system atrophy
- Progressive supranuclear palsy
- Vascular contributions to the above
- Prodromes to the above
- Program opens: May 4, 2018
- LOI deadline: August 1, 2018 at 2:00pm EDT
- Proposal deadline: November 12, 2018 at 2:00pm EST
- Anticipated award notification: January 24, 2019
The Institute welcomes additional inquiries about this program, including whether a potential idea is in scope. For questions related to the Parkinson’s & Related Diseases program, please contact Matthew Sacheli.